1. Home
  2. NAMS vs YETI Comparison

NAMS vs YETI Comparison

Compare NAMS & YETI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • YETI
  • Stock Information
  • Founded
  • NAMS 2019
  • YETI 2006
  • Country
  • NAMS Netherlands
  • YETI United States
  • Employees
  • NAMS N/A
  • YETI N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • YETI Recreational Games/Products/Toys
  • Sector
  • NAMS Health Care
  • YETI Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • YETI Nasdaq
  • Market Cap
  • NAMS 3.1B
  • YETI 2.7B
  • IPO Year
  • NAMS N/A
  • YETI 2018
  • Fundamental
  • Price
  • NAMS $35.94
  • YETI $34.58
  • Analyst Decision
  • NAMS Strong Buy
  • YETI Buy
  • Analyst Count
  • NAMS 10
  • YETI 13
  • Target Price
  • NAMS $43.70
  • YETI $38.83
  • AVG Volume (30 Days)
  • NAMS 1.3M
  • YETI 1.4M
  • Earning Date
  • NAMS 11-06-2025
  • YETI 11-06-2025
  • Dividend Yield
  • NAMS N/A
  • YETI N/A
  • EPS Growth
  • NAMS N/A
  • YETI N/A
  • EPS
  • NAMS N/A
  • YETI 2.10
  • Revenue
  • NAMS $64,006,000.00
  • YETI $1,822,000,000.00
  • Revenue This Year
  • NAMS N/A
  • YETI $3.23
  • Revenue Next Year
  • NAMS N/A
  • YETI $4.82
  • P/E Ratio
  • NAMS N/A
  • YETI $16.48
  • Revenue Growth
  • NAMS 762.15
  • YETI 3.63
  • 52 Week Low
  • NAMS $14.06
  • YETI $26.61
  • 52 Week High
  • NAMS $41.47
  • YETI $45.25
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 59.08
  • YETI 49.74
  • Support Level
  • NAMS $35.50
  • YETI $34.50
  • Resistance Level
  • NAMS $36.81
  • YETI $36.56
  • Average True Range (ATR)
  • NAMS 2.26
  • YETI 1.17
  • MACD
  • NAMS -0.42
  • YETI 0.21
  • Stochastic Oscillator
  • NAMS 22.49
  • YETI 59.63

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About YETI YETI Holdings Inc.

YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.

Share on Social Networks: